---
layout: post
title: "【图解季报】江中药业：2022年一季度归母净利润同比增长15.3%，约为1.8亿元"
date: 2022-04-22 20:16:44 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>江中药业于2022年4月23日披露一季报，公司2022年一季度实现营业总收入9.3亿，同比增长37.4%；实现归母净利润1.8亿，同比增长15.3%；每股收益为0.29元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2E283CC71BE9A5187FEE6BD8F4BDF3014_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2E0B7800AB80483BCC135AB0B79A047D5_w800h400.jpg" alt=""><p><strong>期间费用率升高6.2%，经营性现金流大幅下降130.9%</strong></p><p>公司2022一季度营业成本3亿，同比增长25.8%，低于营业收入37.4%的增速，导致毛利率上升2.9%。期间费用率为44.2%，较上年升高6.2%。经营性现金流由6340.2万下降至-1955.9万，同比下降130.9%。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D28DFD2D20B64288E205726B16909461D4_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204222354395431>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)